Table 2.
Characteristics of patients entered into the registry.
| All pilot hospitals | App patients (n = 84) | NON app patients (n = 276) | P-value |
|---|---|---|---|
| Males | 44 (52.3%) | 149 (54%) | 0.8 |
| LVO | 36 (42.8%) | 153 (55.4%) | <0.05 |
| Mean age | 60 ± 5 y | 63 ± 2 y | <0.0001 |
| Mean NIHSS | 14.5 ± 2.5 | 10.4 ± 3.6 | <0.0001 |
| Recurrent stroke/TIA | 21 (25%) | 60 (21.7%) | 0.6 |
| Stroke subtype (TOAST) | |||
| Cardioembolic, n (%) | 28 (33.3%) | 87 (31.5%) | 0.78 |
| Large vessel athrosclerosis, n (%) | 26 (30.9%) | 102 (37%) | 0.36 |
| Lacunar, n (%) | 14 (16.6%) | 43 (15.6%) | 0.86 |
| Mortality at 3 mo, n (%) | 8 (9.5%) | 31 (11.2%) | 0.84 |
| Functional independence (mRS <3) at 3 mo, n (%) | 57 (67.9%) | 130 (47.1%) | 0.0011 |
| sICH | 4 (4.8%) | 14 (5.1%) | > 0.05 |
LVO, large vessel occlusion; NIHSS, National Institute of Health Stroke Scale; TIA, transient ischemic attack; TOAST, Trial of Org 10172 in Acute Stroke Treatment (stroke classification); sICH, symptomatic intracerebral hemorrhage.